2022 Annual Meeting Virtual Experience | PL2 - Controversies in Neurology Plenary Session
Program Materials Program Evaluations
| 05:30 PM - 05:35 PM EDT | Introduction |
Introduction
Martinson K. Arnan, MD, FAAN |
| 05:35 PM - 05:47 PM EDT | Speaker |
Yes: Aducanumab: To Prescribe or Not Prescribe
Alireza Atri, MD, PhD |
| 05:47 PM - 05:59 PM EDT | Speaker |
No: Aducanumab: To Prescribe or Not Prescribe
David S. Knopman, MD, FAAN |
| 05:59 PM - 06:04 PM EDT | Speaker |
Rebuttal: Aducanumab: To Prescribe or Not Prescribe
Alireza Atri, MD, PhD |
| 06:04 PM - 06:09 PM EDT | Speaker |
Rebuttal: Aducanumab: To Prescribe or Not Prescribe
David S. Knopman, MD, FAAN |
| 06:09 PM - 06:30 PM EDT | Q&A |
Fireside Chat
Martinson K. Arnan, MD, FAAN, David S. Knopman, MD, FAAN, Alireza Atri, MD, PhD |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Alireza Atri, MD, PhD | Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Atri has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lunbeck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. The institution of Dr. Atri has received research support from National Institute of Aging (NIA). The institution of Dr. Atri has received research support from AZ Department of Health Services. The institution of Dr. Atri has received research support from Gates Ventures. The institution of Dr. Atri has received research support from Multiple companies, universities & consortia for contracted clinical trials to institution. The institution of Dr. Atri has received research support from Washington University in St. Louis. The institution of Dr. Atri has received research support from Foundation for NIH. The institution of Dr. Atri has received research support from ACTC/NIH. Dr. Atri has received publishing royalties from a publication relating to health care. |
| Martinson K. Arnan, MD, FAAN | Dr. Arnan has nothing to disclose. |